FDA.reportPublic FDA data

Application 061884

Type
ANDA
Sponsor
SANOFI AVENTIS US

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001RIFAMATEISONIAZID; RIFAMPINCAPSULE;ORAL150MG;300MGNoYes

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0068-0509Rifamaterifampin and isoniazidsanofi-aventis U.S. LLCANDACurrent
0068-0509Rifamaterifampin and isoniazidsanofi-aventis U.S. LLCANDACurrent
0068-0509Rifamaterifampin and isoniazidsanofi-aventis U.S. LLCANDACurrent
0068-0509Rifamaterifampin and isoniazidsanofi-aventis U.S. LLCANDACurrent